Insider · CIK 0001830908
Timothy Mark Dyer
ceoofficerdirector
Files at ADXN (Addex Therapeutics Ltd.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | ADXN Addex Therapeutics Ltd. | DDisposition to issuer Common Stock | -16,413,787 | $0.00 | $0 | 435,192 | 39 d ago |
| Sep 2, 2026 | ADXN Addex Therapeutics Ltd. | AGrant or award Common Stock | +16,413,787 | $0.00 | $0 | 16,848,979 | 39 d ago |
| Sep 2, 2026 | ADXN Addex Therapeutics Ltd. | DDisposition to issuer Stock-option (Right to Buy)derivative | -3,369,796 | $0.00 | $0 | 0 | 39 d ago |
| Sep 2, 2026 | ADXN Addex Therapeutics Ltd. | AGrant or award Stock-option (Right to Buy)derivative | +3,369,796 | $0.00 | $0 | 3,369,796 | 39 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.